Vistagen Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	47.37	67.13	119.17	16.64	68.14	103.11
Short-Term Investments	14.4	13.35	-	-	-	-
Cash & Short-Term Investments	61.77	80.48	119.17	16.64	68.14	103.11
Cash Growth	-30.25%	-32.46%	616.23%	-75.58%	-33.92%	7508.91%
Other Current Assets	1.48	1.59	1.51	0.87	2.86	1.01
Total Current Assets	63.25	82.08	120.67	17.51	71	104.12
Net Property, Plant & Equipment	1.42	1.81	2.26	2.77	3.08	3.59
Other Long-Term Assets	0.39	0.45	0.73	0.82	0.57	0.58
Total Assets	65.06	84.34	123.65	21.09	74.64	108.28
Accounts Payable	1.28	0.65	1.55	2.47	2.76	0.84
Accrued Expenses	9.25	8.81	2.24	0.8	1.33	1.56
Short-Term Debt	0.38	-	-	0.11	-	-
Current Portion of Leases	0.62	0.56	0.55	0.49	0.43	0.37
Unearned Revenue	2	2.59	0.79	0.71	1.24	1.42
Total Current Liabilities	13.53	12.61	5.12	4.57	5.77	4.19
Long-Term Leases	0.43	0.95	1.57	2.12	2.61	3.35
Other Long-Term Liabilities	0.18	0.39	2.67	2.32	1.56	8.76
Total Long-Term Liabilities	0.61	1.34	4.24	4.44	4.16	12.11
Total Liabilities	14.14	13.95	9.37	9.01	9.93	16.3
Preferred Stock	-	-	-	-	-	0
Common Stock	0.04	0.03	0.03	0.01	0.01	0.18
Treasury Stock	-3.97	-3.97	-3.97	-3.97	-3.97	-3.97
Additional Paid-in Capital	515.88	481.96	474.44	342.89	336.28	315.6
Accumulated Other Comprehensive Income	0.01	0.01	-	-	-	-
Retained Earnings	-461.04	-407.63	-356.21	-326.85	-267.6	-219.84
Shareholders' Equity	50.92	70.39	114.29	12.08	64.72	91.98
Total Liabilities & Equity	65.06	84.34	123.65	21.09	74.64	108.28
Total Debt	1.43	1.51	2.12	2.71	3.04	3.72
Net Cash (Debt)	60.34	78.97	117.05	13.93	65.1	99.39
Net Cash Growth	-23.59%	-32.53%	740.43%	-78.61%	-34.50%	-
Net Cash Per Share	1.71	2.56	6.05	2.00	9.86	34.62
Book Value	50.92	70.39	114.29	12.08	64.72	91.98
Book Value Per Share	1.44	2.28	5.90	1.74	9.81	32.04
Tangible Book Value	50.92	70.39	114.29	12.08	64.72	91.98
Tangible Book Value Per Share	1.44	2.28	5.90	1.74	9.81	32.04

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q